Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
SWOG Cancer Research Network
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)